Efficiency of first-trimester uterine artery doppler, a-disintegrin and metalloprotease 12, pregnancy-Associated plasma protein a, and maternal characteristics in the prediction of preeclampsia

Journal of Ultrasound in Medicine

Volumn 32, Issue 9, 2013, Pages 1593-1600

  Goetzinger, Katherine R ^a   Zhong, Yan ^a   Cahill, Alison G ^a   Odibo, Linda ^a   Macones, George A ^a   Odibo, Anthony O ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

A disintegrin and metalloprotease 12; Placental dysfunction; Preeclampsia; Pregnancy Associated plasma protein A; Uterine artery Doppler sonography

Indexed keywords

FORECASTING; REGRESSION ANALYSIS; ULTRASONIC IMAGING;

DOPPLER SONOGRAPHY; METALLO-PROTEASE; PLACENTAL DYSFUNCTION; PLASMA PROTEIN; PREECLAMPSIA;

EFFICIENCY;

ADAM PROTEIN; BIOLOGICAL MARKER; MACROPHAGE ELASTASE; PAPPA1 PROTEIN, HUMAN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

A-DISINTEGRIN AND METALLOPROTEASE 12; ADULT; ARTICLE; BLOOD; DOPPLER FLOWMETRY; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; METHODOLOGY; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN A; PREVALENCE; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS; UNITED STATES; UTERINE ARTERY; UTERINE ARTERY DOPPLER SONOGRAPHY; PRE-ECLAMPSIA; PROCEDURES; STATISTICS AND NUMERICAL DATA;

A-DISINTEGRIN AND METALLOPROTEASE 12; PLACENTAL DYSFUNCTION; PREECLAMPSIA; PREGNANCY-ASSOCIATED PLASMA PROTEIN A; UTERINE ARTERY DOPPLER SONOGRAPHY;

ADAM PROTEINS; ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 12; MISSOURI; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER; UTERINE ARTERY;

EID: 84883386840     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/ultra.32.9.1593     Document Type: Article

References (21)

1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin 33: Diagnosis and Management of Preeclampsia and Eclampsia. Washington, DC: American College of Obstetricians and Gynecologists: 2002.
2. Confidential Enquiry Into Maternal and Child Health. Perinatal Mortality: England, Wales and Northern Ireland. London, England: Confidential Enquiry Into Maternal and Child Health; 2008.
3. Dugoff L, Hobbins JC, Malone FD, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004; 191:1446-1451.
4. Smith GCS, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-Associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia and stillbirth. J Clin Endocrinol Metab 2002; 87:1762-1767.
5. Ong CYT, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000; 107:1265-1270.
6. Goetzinger KR, Singla A, Gerkowicz S, Dicke JM, Gray DL, Odibo AO. Predicting the risk of pre-eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free ®-hCG. Prenat Diagn 2010; 30:1138-1142.
7. Laigaard J, Sorensen T, Placing S, et al. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol2005; 106:144-149.
8. Spencer K, Cowans NJ, Stamatopoulou A. ADAM12s in maternal serum as a potential marker of pre-eclampsia. Prenat Diagn 2008; 28:212-216.
9. Poon LCY, Chelemen T, Granvillano O, Pandeva I, Nicolaides KH. Firsttrimester maternal serum A-disintegrin and metalloprotease (ADAM12) and adverse pregnancy outcome. Obstet Gynecol 2008; 112:1082-1090.
10. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18:583-586.
11. Parra M, Rodrigo R, Barja P, et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obset Gynecol 2005; 193:1486-1491.
12. Gomez O, Martinez JM, Figueras F, et al. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol 2005; 26:490-494.
13. Vainio M, Kujansuu E, Koivisto AM, Maenpaa J. Bilateral notching of uterine arteries at 12-14 weeks of gestation for prediction of hypertensive disorders of pregnancy. Acta Obstet Gynecol Scand 2005; 84:1062-1067.
14. Pilalis A, Souka AP, Antsaklis P, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound Obstet Gynecol 2007; 29:135-140.
15. Melchiorre K, Wormald B, Leslie K, Bhide A, Thilaganathan B. First-trimester uterine artery Doppler indices in term and preterm preeclampsia. Ultrasound Obstet Gynecol 2008; 32:133-137.
16. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
17. Loechel F, Fox JW, Murphy G, Albrechsten R, Wewer UM. ADAM12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 2000; 278:511-515.
18. Shi Z, Xu W, Loechel F, Wewer UM, Murphy LJ. ADAM12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3. J Biol Chem 2000; 275:18574-18580.
19. Caniggia I, Winter J, Lye SJ, Post M. Oxygen and placental development during the first trimester: implications for the pathophysiology of preeclampsia. Placenta 2000; 21(suppl A):S25-S30.
20. Parra-Cordero M, Rodrigo R, Barja P, et al. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first-trimester of pregnancy. Ultrasound Obstet Gynecol 2013; 41:538-544.
21. Poon LCY, Staboulidou I, Maiz N, Plasencia W, Nicolaides KH. Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11-13 weeks. Ultrasound Obstet Gynecol 2009; 34:142-148.